低分子肝素钙联合α-硫辛酸对糖尿病足的疗效
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金委员会资助项目(81673975)


Efficacy and mechanism of low molecular weight heparin calcium combined with α-lipoic acid in the treatment of diabetic foot
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨低分子肝素钙联合α-硫辛酸对糖尿病足的疗效及作用机制。方法 回顾性分析2019年1月—2022年12月在我院接受治疗的糖尿病足患者89例,按照治疗方式的不同分为观察组(44例)和对照组(45例)。两组患者在常规治疗的基础上,对照组采用α-硫辛酸治疗,观察组采用低分子肝素钙联合α-硫辛酸联合治疗,比较两组患者治疗前后的经皮氧分压(TcPO2)值、足背动脉血流速度和半径、血清指标变化、治疗后的溃疡面积、创面肉芽情况、临床疗效及不良反应情况。结果 治疗后,两组患者的TcPO2值均较治疗前降低,且观察组显著低于对照组(P<0.05)。治疗前,两组足背动脉血流速度和足背动脉内径差异无统计学意义(P>0.05),治疗后,观察组与对照组相比增高明显(P<0.05)。治疗前,两组血清IL-6、基质金属蛋白(MMP)-2及MMP-9差异无统计学意义(P>0.05),治疗后,观察组血清Il-6、MMP-2、MMP-9水平均低于对照组(P<0.05)。治疗后,观察组溃疡面积、创面肉芽改善优于对照组(P<0.05);观察组的临床治疗总有效率高于对照组(P<0.05);观察组的不良反应发生率与对照组对比差异无统计学意义(P>0.05)。结论 给予糖尿病足患者低分子肝素钙与α-硫辛酸联合干预,有利于改善患者肢端局部缺血,增加足部血液循环,促进创面愈合,提高临床治疗效果,且不良反应较少,可供临床借鉴

    Abstract:

    Objective To explore the efficacy and mechanism of low molecular weight heparin calcium combined with α-lipoic acid in the treatment of diabetic foot. Methods A retrospective analysis of 89 diabetic foot patients who received treatment in our hospital from 2019 to 2022 was divided into observation group (44 cases) and control group (45 cases) according to different treatment methods. Above, the control group was treated with α-lipoic acid, the observation group was treated with low molecular weight heparin calcium combined with α-lipoic acid. The TcPO2 value, the blood flow velocity and radius of the dorsal artery of the foot, the changes of serum indexes, the ulcer area, wound granulation, clinical efficacy and adverse reactions were compared between the two groups before and after treatment. Results After treatment, the TcPO2 values of the two groups of patients were lower than those before treatment, and the observation group was significantly lower than the control group (P<0.05). After treatment, the observation group was significantly higher than the control group (P<0.05). Before treatment, there was no significant difference in serum IL-6, MMP-2 and MMP-9 between the two groups (P>0.05). After treatment, the levels of each index in the observation group were lower than those in the control group (P<0.05). After treatment, the improvement of ulcer area and wound granulation in the observation group were better than those in the control group, and were comparable (P<0.05). The total effective rate of clinical treatment was higher than that of the control group (P<0.05). The incidence of adverse reactions in the observation group was compared with that in the control group (P>0.05).Conclusion The combined intervention of low molecular weight heparin calcium and α-lipoic acid in diabetic foot patients is beneficial to improve extremity ischemia, increase foot blood circulation, promote wound healing, and improve clinical treatment effect, and has fewer adverse reactions, which is worthwhile of clinical promotion and application

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司